Wednesday, October 15, 2014

FDA Enforcement Reports: List Recall from New England Home Therapies(subsidiary of BioScrip) of all sterile drugs compounding between 2/21/14 and 2/24/14 due to a lack of sterility assurance

  • New England Home Therapies recalled all sterile drugs compounded between 2/21/14 and 2/24/14 due to a lack of sterility assurance. The company is a subsidiary of BioScrip and provides products for heart failure, hemophilia, and oncology, among others.

No comments: